The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: A retrospective cohort study

Gynecologic Oncology

Volumn 132, Issue 3, 2014, Pages 551-555

  So, Kyeong A ^a   Hong, Jin Hwa ^a   Jin, Hye Mi ^a   Kim, Jae Won ^b   Song, Jae Yun ^c   Lee, Jae Kwan ^a   Lee, Nak Woo ^b  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c College of Medicine   (South Korea)

Author keywords

Leukocytosis; Ovarian cancer; Overall survival; Recurrence free survival

Indexed keywords

CARBOPLATIN; PACLITAXEL; PLATINUM;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS;

LEUKOCYTOSIS; OVARIAN CANCER; OVERALL SURVIVAL; RECURRENCE-FREE SURVIVAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKOCYTOSIS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PACLITAXEL; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84896393893     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.01.010     Document Type: Article

References (41)

1. S. Pandit, S. Choudhury, S.K. Das, and S. Nandi Leucocytosis in a case of lung cancer: infection or paraneoplastic syndrome? - dilemma in diagnosis and treatment Med J Malaysia 67 2012 542 544
2. M.J. Worley Jr., C.C. Nitschmann, M. Shoni, A.F. Vitonis, J.A. Rauh-Hain, and C.M. Feltmate The significance of preoperative leukocytosis in endometrial carcinoma Gynecol Oncol 125 2012 561 565
3. L.C. Pelosof, and D.E. Gerber Paraneoplastic syndromes: an approach to diagnosis and treatment Mayo Clin Proc 85 2010 838 854
4. S. Mabuchi, Y. Matsumoto, F. Isohashi, Y. Yoshioka, H. Ohashi, and E. Morii et al. Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer Gynecol Oncol 122 2011 25 32
5. S.J. Chang, R.E. Bristow, and H.S. Ryu Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer J Gynecol Oncol 24 2013 29 36
6. S. Raungkaewmanee, S. Tangjitgamol, S. Manusirivithaya, S. Srijaipracharoen, and T. Thavaramara Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer J Gynecol Oncol 23 2012 265 273
7. C.H. Holschneider, and J.S. Berek Ovarian cancer: epidemiology, biology, and prognostic factors Semin Surg Oncol 19 2000 3 10
8. L. Lu, E. Risch, Q. Deng, N. Biqlia, E. Picardo, and D. Katsaros et al. An insulin-like growth factor-II intronic variant affects local DNA conformation and ovarian cancer survival Carcinogenesis 34 2013 2024 2030
9. Q.H. Meng, E. Xu, M.A. Hildebrandt, D. Liang, K. Lu, and Y. Ye et al. Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome Clin Chem 60 2014 222 232
10. T. Kuroda, Y. Hirohashi, T. Toriqoe, K. Yasuda, A. Takahashi, and H. Asanuma et al. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH high expression is associated with poor prognosis PLoS One 8 2013 e65158
11. S.V. Shmelkov, J.M. Butler, A.T. Hooper, A. Hormigo, J. Kushner, and T. Milde et al. CD133 expression is not restricted to stem cells, and both CD133 + and CD133- metastatic colon cancer cells initiate tumors J Clin Invest 118 2008 2111 2120
12. J. Burkert, W.R. Otto, and N.A. Wright Side populations of gastrointestinal cancers are not enriched in stem cells J Pathol 214 2008 564 573
13. L. Lu, D. Katsaros, S.T. Mayne, H.A. Risch, C. Benedetto, and E.M. Canuto et al. Functional study of risk loci of stem cell-associated gene lin-28B and associations with disease survival outcomes in epithelial ovarian cancer Carcinogenesis 33 2012 2119 2125
14. H. Yang, W. Kong, L. He, J.J. Zhao, J.D. O'Donnell, and J. Wang et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN Cancer Res 68 2008 425 433
15. M.V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, and P. Casalini et al. MicroRNA signatures in human ovarian cancer Cancer Res 67 2007 8699 8707
16. N. Yang, S. Kaur, S. Volinia, J. Greshock, H. Lassus, and K. Hasegawa et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer Cancer Res 68 2008 10307 10314
17. X. Hu, D.M. Macdonald, P.C. Huettner, Z. Feng, I.M. El Naga, and J.K. Schwarz et al. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer Gynecol Oncol 114 2009 457 464
18. L. Lu, P. Schwartz, L. Scarampi, T. Rutherford, E.M. Canuto, and H. Yu et al. MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management Gynecol Oncol 122 2011 366 371
19. L. Lu, D. Katsaros, I.A. de la Longrais, O. Sochirca, and H. Yu Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis Cancer Res 67 2007 10117 10122
20. M. Tomita, T. Shimizu, M. Hara, T. Ayabe, and T. Onitsuka Preoperative leukocytosis, anemia, and thrombocytosis are associated with poor survival in non-small cell lung cancer Anticancer Res 29 2009 2687 2690
21. M.H. Chen, P.M. Chang, P.M. Chen, C.H. Tzeng, P.Y. Chu, and S.Y. Chang et al. Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer J Cancer Res Clin Oncol 135 2009 1783 1790
22. Y. Shoenfeld, A. Tal, S. Berliner, and J. Pinkhas Leukocytosis in nonhematological malignancies: a possible tumor-associated marker J Cancer Res Clin Oncol 111 1986 54 58
23. H.W. Bruckner, P.T. Lavin, S.C. Plaxe, J.A. Storch, and E.M. Livstone Absolute granulocyte, lymphocyte, and monocyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach JAMA 247 1982 1004 1006
24. M. Lee, S.W. Kim, E.J. Nam, G.W. Yim, S. Kim, and Y.T. Kim The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer Gynecol Oncol 122 2011 238 241
25. J.H. Kim, J.M. Lee, K.S. Ryu, Y.S. Lee, Y.G. Park, and S.Y. Hur et al. The prognostic impact of duration of anemia during chemotherapy in advanced epithelial ovarian cancer Oncologist 16 2011 1154 1161
26. I. Kasuga, S. Makino, H. Kiyokawa, H. Katoh, Y. Ebihara, and K. Ohyashiki Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma Cancer 92 2001 2399 2405
27. S.M. Nasser, U.H. Choudry, G.P. Nielsen, and M.J. Ott A leukemoid reaction in a patient with a dedifferentiated liposarcoma Surgery 129 2001 765 767
28. M. Watanabe, K. Ono, Y. Ozeki, S. Tanaka, S. Aida, and Y. Okuno Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma Jpn J Clin Oncol 28 1998 559 562
29. M. Wetzler, Z. Estrov, M. Talpaz, A. Markowitz, J.U. Gutterman, and R. Kurzrock Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma J Intern Med 234 1993 417 420
30. K.M. Qureshi, A.K. Raman, D. Tan, and M.G. Fakih Leukemoid reaction in pancreatic cancer: a case report and review of the literature JOP 7 2006 631 634
31. K. Sato, Y. Fujii, M. Ono, H. Nomura, and K. Shizume Production of interleukin 1 alpha-like factor and colony-stimulating factor by a squamous cell carcinoma of the thyroid (T3M-5) derived from a patient with hypercalcemia and leukocytosis Cancer Res 47 1987 6474 6480
32. S. Asano, A. Urabe, T. Okabe, N. Sato, and Y. Kondo Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue Blood 49 1977 845 852
33. M.Y. Lee, K. Kaushansky, S.A. Judkins, J.L. Lottsfeldt, A. Waheed, and R.K. Shadduck Mechanisms of tumor-induced neutrophilia: constitutive production of colony-stimulating factors and their synergistic actions Blood 74 1989 115 122
34. J.P. Connor Aggressive carcinosarcoma of the uterine cervix associated with high levels of granulocyte colony stimulating factor: case report and laboratory correlates Gynecol Oncol 103 2006 349 353
35. I.A. Shameem, H. Kurish, H. Matsuyama, T. Shimabukuro, and K. Naito Direct and indirect effects of recombinant human granulocyte-colony stimulating factor on in vitro colony formation of human bladder cancer cells Cancer Immunol Immunother 38 1994 353 357
36. G. Scambia, U. Testa, P. Benedetti Panici, E. Foti, R. Martucci, and A. Gadducci et al. Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer Br J Cancer 71 1995 354 356
37. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
38. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545
39. H.B. Cho, H.W. Hur, S.W. Kim, S.H. Kim, J.H. Kim, and Y.T. Kim et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment Cancer Immunol Immunother 58 2009 15 23
40. T. Gungor, M. Kanat-Pektas, A. Sucak, and L. Mollamahmutoglu The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors Arch Gynecol Obstet 279 2009 53 56
41. S. Bishara, M. Griffin, A. Cargill, A. Bali, M.E. Gore, and S.B. Kaye et al. Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer Eur J Obstet Gynecol Reprod Biol 138 2008 71 75